Biomarker Partnering Terms and Agreements: Strongly Driven by Advances in Personalized Medication for Chronic Diseases
Albany, US, 2019-Jan-21 — /EPR Network/ —Burgeoning advances in personalized medication to target specific disease triggers and develop corresponding therapeutics has necessitated biomarker deals across [read full press release…]